Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters
 

Liuying Township, Taiwan Clinical Trials

A listing of Liuying Township, Taiwan clinical trials actively recruiting patients volunteers.

RESULTS

Found (13554) clinical trials

Do you have a Lyme Rash (Bulls Eye)? If yes, then you can help! Call or visit to learn more about a diagnostic study run by Oxford Immunotex, Inc. in collaboration with Rapid Medical Research, Inc. www.rapidmedicalresearch.com Eligibility Criteria: Experiencing Lyme Rash (Bulls Eye Rash)

Phase N/A

The study purpose is to examine whether there are structural or functional differences in the brains of individuals who use cocaine or amphetamines as opposed to control participants who have never used cocaine or amphetamines. More specifically, it will allow the investigator to see how the brain changes once people ...

Phase N/A

Pompe Pregnancy Sub-Registry

Study Design Time Perspective: Retrospective and Prospective

Phase N/A

Medical Abortion up to 10 Weeks Gestation at Home

The study will include 600 women opting for medical abortion. Women wanting to perform the last part of the abortion in their homes will be invited to participate. 300 women with a pregnancy up to 9 weeks of gestation (63 days) will be compared to 300 women with a gestation ...

Phase N/A

Development of Non-invasive Prenatal Screening Test for Microdeletions Based on Fetal DNA Isolated From Maternal Blood

The goal of this study is to further develop a non-invasive prenatal blood test that can diagnose genetic disorders in the fetus by looking at fetal DNA (genetic material) found in the mother's bloodstream during pregnancy. Women carrying a fetus diagnosed with microdeletions/microduplications (small missing or extra pieces of DNA ...

Phase N/A

EROSION II: OCT Guided PPCI in STEMI

This protocol describes a perspective,multicenter study intended to test the hypothesis that patients with STEMI caused by plaque rupture or plaque erosion without obstructive stenosis (diameter stenosis <70%) can be stabilized by effective antithrombotic treatment without stent implantation, thereby avoiding both early and late complications related to percutaneous coronary intervention ...

Phase N/A

Longitudinal Performance of Epi proColon

Epi proColon is blood based screening test for colorectal cancer that is FDA - PMA approved. It is indicated for average risk patients who are unwilling or unable to be screened with other recommended screening tests, including colonoscopy or fecal occult blood tests. The PERT study is designed to assess ...

Phase N/A

Early Rebiopsy to Identify Biomarkers of Tumor Cell Survival Following EGFR ALK ROS1 or BRAF TKI Therapy

A comparison of baseline tumor characteristics in oncogene-driven cancers to tumor characteristics after early response to Tyrosine Kinase Inhibitor (TKI) targeted treatment will allow identification of early adaptive mechanisms of cell survival. This will facilitate targeting and termination of these survival/ resistance pathways before they develop with rational combinations of ...

Phase N/A

A clinical trial sponsored by China National Center for Cardiovascular Diseases for a research study for the treatment of Percutaneous Coronary Intervention, Coronary Artery Disease, Intravascular Ultrasound, Chronic Total Occlusion of Coronary Artery, Coronary heart disease

The study plan to include the patients with a CTO lesion in one of the three main epicardial coronary artery (diameter more than 2.5 mm) as the only target lesion. The CTO lesion is defined as 0 grade of thrombolysis in myocardial infarction (TIMI) flow with evidence of occlusion duration ...

Phase N/A

Evaluation of the Frequency of Occurrence of Joint Pain With Bevacizumab in Patients With Ovarian Colorectal or Bronchopulmonary Cancer

Self-administered questionnaire survey to determine the presence or absence of joint pain during bevacizumab treatment for lung, ovarian, colorectal cancers. The principal end-point is the frequency of arthralgia after 6 months of treatment with Bevacizumab.

Phase N/A